MedTrace Logo

MR-based Collateral Imaging to Predict Response to Endovascular Treatment of Stroke (FAST-COLL Study)

NCT02668627 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2017-04-26

No results posted yet for this study

Summary

Based on the results of recent randomized controlled trials, current international guidelines recommend the initiation of endovascular treatment within 6 hours of symptom onset for acute ischemic stroke. Endovascular treatment may be beneficial in selected patients beyond 6 hour time window. In particular, treatment response to endovascular therapy may be greatly influenced by pretreatment collateral status. The aim of this study is to evaluate whether MRI-based collateral imaging (the Fast Analysis SysTem for COLLaterals, 'FAST-COLL') is feasible and can predict the response to endovascular treatment in a wide range of patients with acute ischemic stroke .

Conditions

Interventions

PROCEDURE

Endovascular treatment

Endovascular mechanical thrombectomy or endovascular delivery of thrombolytic agent

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Oh Young Bang, MD · Samsung Medical Center

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2017-12-31
Completion
2018-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02668627 on ClinicalTrials.gov